Interleukin (IL)-13 plays a key role in type 2 inflammation and is an emerging pathogenic mediator in atopic dermatitis.
http://ift.tt/2DgYt5m
Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
▼
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
-
▼
Ιανουαρίου
(3198)
-
▼
Ιαν 15
(51)
- Systematic review of atopic dermatitis disease def...
- Dermatology Training Across the Globe
- Computerized planimetry to assess clinical respons...
- Vulvo-vaginal rejuvenation: Fact or fiction? Fract...
- Predictive factors for pharyngocutaneous fistuliza...
- Future Meetings
- Breast-Milk Iodine Concentrations and Iodine Level...
- Thyroid-Related Research in Japan A Spotlight on R...
- Genotype-Based Epigenetic Differences in Monozygot...
- Treatment of allergic rhinitis using mobile techno...
- The EAACI/GA²LEN/EDF/WAO Guideline for the Definit...
- Efficacy and safety of fezakinumab (an anti-IL-22 ...
- Efficacy and safety of lebrikizumab (an anti-IL-13...
- Acrodermatitis acidaemica
- Is there an association of ABO blood groups and Rh...
- Abscopal effects of radiotherapy and combined mRNA...
- The role of T2*-weighted gradient echo in the diag...
- Could conjunctivitis in dupilumab treated atopic d...
- Clinical Thyroidology for the Public – Highlighted...
- A Significant Treatable Cause of Hearing Loss in O...
- Antegrade Arterial and Portal Flushing Versus Port...
- Midterm Outcome of Kidney Transplantation from Don...
- Beyond JAAD April 2018
- Evaluation of recombinant factor VIIa, tranexamic ...
- Comparing peri-operative complications of paediatr...
- Chronological Progression of an Enlarged Styloid P...
- The ethics of interventional procedures for patien...
- Oxygen in the critically ill: friend or foe?
- Deep vein thrombosis and venous thromboembolism in...
- Activation state of circulating eosinophils in nas...
- Preclinical therapeutic efficacy of the ciprofloxa...
- Antibiotic use patterns in endoscopic sinus surger...
- Prevalence of metabolic syndrome in children with ...
- Clinical evaluation of a novel fractional radiofre...
- Quality of life and problems associated with obtur...
- Granular cell tumors of the tongue: fibroma or sch...
- The Infinity from Nothing paradox and the Immovabl...
- Childhood alopecia areata—Data from the National A...
- Use of antiviral medications in drug reaction with...
- A comprehensive next-generation sequencing assay f...
- Oxybutynin 3% gel for the treatment of primary foc...
- Severe ectropion in lamellar ichthyosis managed me...
- Neurological prognosis of 6 cases after chest comp...
- A comparison of semi-automated volumetric vs linea...
- Patient-Reported-Outcome-Messung (PROM) psychosozi...
- Neue diagnostische und therapeutische Aspekte zu C...
- T cell responses to tumor: how dominant assumption...
- A photonumeric scale for the assessment of atrophi...
- Could conjunctivitis in dupilumab treated atopic d...
- Issue Information - Cover and Editorial Board
- Issue Information - TOC
-
▼
Ιαν 15
(51)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
►
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Δευτέρα 15 Ιανουαρίου 2018
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου